The IGF-I/IGF-IR Signaling System and Pancreatic Cancer


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Ductal adenocarcinoma is one of the most common and severely aggressive forms of pancreatic cancer. IGF-I is one of the factors that ensures survival and proliferation of tumor cells, and its increased concentration inside the tumor is a characteristic sign of many malignant formations. The goal of this minireview is to provide an up-to-date insight on the roles of the IGF-I/IGF-IR signaling pathway in carcinogenesis and potential opportunities for pharmacologic targeting of IGF-I/IGF-IR in pancreatic tumors.

Sobre autores

E. Kopantzev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Autor responsável pela correspondência
Email: kopantzev@ibch.ru
Rússia, Moscow, 117997

E. Grankina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Rússia, Moscow, 117997

M. Kopantseva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Rússia, Moscow, 117997

E. Sverdlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: kopantzev@ibch.ru
Rússia, Moscow, 117997

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2017